Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Join | Sign in
Home>Products>Product Directory>Cryopreservation, Cyrovials
  Product Directory
More information
Cryopreservation, Cyrovials & Storage

Culture Kit for human ES/iPS cells
ReproCell Products
Request a quote
More information
DataPaq™ Cryorack Scanner
Ziath Ltd
Request a quote
More information
DataPaq™ Deep Focus AV6 Scanner
Ziath Ltd
Request a quote
More information
DataPaq™ High Speed A4 Rack Scanner
Ziath Ltd
Request a quote
More information
DataPaq™ High Speed A6 Rack Scanner
Ziath Ltd
Request a quote
More information
DataPaq™ High Speed Single Tube Scanner
Ziath Ltd
Request a quote
More information
DataPaq™ Linear Rack Barcode Scanner
Ziath Ltd
Request a quote
More information
Freezing Medium for Human ES/iPS cells
ReproCell Products
Request a quote
More information
Microtube Defroster
Ziath Ltd
Request a quote
More information
Microtube Picker
Ziath Ltd
Request a quote
More information
<< 1 2 >>
Showing Results 1 - 10 of 13
Scientific News
NIH-Sponsored HIV Vaccine Trial Launches In South Africa
Early-stage trial aims to build on RV144 results.
New Class of Antibodies Raises Hope of Dengue Fever Vaccine
Scientists have discovered a new class of human antibodies against the dengue fever virus, which could be exploited to develop a vaccine.
Ebola Vaccine Trial Opens in Liberia
Study led by Liberia-NIH partnership will test two experimental vaccines.
Beating The Clock: New Treatment For Rabies Developed
University of Georgia researchers have developed a new treatment for rabies.
Utilizing Fast HPLC Screening Methods for the Detection of Steroids
Analysis of steroids improved by choosing the optimal HPLC column for the separation.
New Approach May Lead to Inhalable Vaccines
The approach using nanoparticles could lead to development of inhalable vaccines for influenza, pneumonia and tuberculosis.
New Mouse Study Method Enables Comparative Vaccine Studies for Tularemia
The study appears online in Clinical Vaccine and Immunology.
Oxford Vaccine Group Begins First Trial of New Ebola Vaccine
Oxford University doctors and scientists are starting the first safety trial of an experimental preventative Ebola vaccine regimen being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen).
UMMS Receives $6.1 M to Develop Model for Predicting Gene Expression
Insight into regulation of the genes that allow the immune system to recognize pathogens will help scientists rationally design new vaccines and prevent autoimmunity.
GRP78 Protein Possible Universal Therapeutic Target
Drug combination including Viagra is effective tool in targeting the protein.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters